Chareyron2009 - Mixed immunotherapy and chemotherapy of tumors Feedback design and model updating schemes Lab

{
  "io": {
    "inputs": [
      {
        "name": "initial_tumor_cells",
        "label": "Tumor Cells",
        "units": "native SBML value",
        "default": 50000000,
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.initial_tumor_cells",
        "description": "Initial Tumor Cells. Sets the initial value of bundled SBML symbol `T`."
      },
      {
        "name": "chemotherapy_drug_level",
        "label": "Chemotherapy Drug Level",
        "units": "native SBML value",
        "default": 2.34000000000344,
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.chemotherapy_drug_level",
        "description": "Chemotherapy Drug Level. Overrides bundled SBML parameter `D`."
      }
    ],
    "outputs": [
      {
        "name": "tumor_cells",
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.tumor_cells",
        "description": "Tumor Cells observable. Maps to SBML symbol `T`."
      },
      {
        "name": "state",
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.state",
        "description": "Full raw SBML observable record for reproducibility and downstream visualisation."
      },
      {
        "name": "summary",
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.summary",
        "description": "Change and peak summary across the simulated SBML observables."
      },
      {
        "name": "species_labels",
        "maps_to": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.species_labels",
        "description": "Mapping from selected raw SBML observable symbols to display labels."
      }
    ]
  },
  "tags": [
    "biomodels_ebi",
    "chemotherapy",
    "curated",
    "drug-response",
    "faithful",
    "immunology",
    "immunotherapy",
    "microenvironment",
    "oncology",
    "pharmacology",
    "physiology",
    "sbml",
    "systemsbiology",
    "tumor-growth"
  ],
  "title": "Chareyron2009 - Mixed immunotherapy and chemotherapy of tumors Feedback design and model updating schemes Lab",
  "models": [
    {
      "path": "owned/models/oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model",
      "alias": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model",
      "provenance": {
        "owned_path": "owned/models/oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model"
      }
    },
    {
      "path": "owned/models/visualisation",
      "alias": "visualisation",
      "provenance": {
        "owned_path": "owned/models/visualisation"
      }
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model_state"
      ],
      "from": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.state"
    },
    {
      "to": [
        "visualisation.oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model_summary"
      ],
      "from": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.summary"
    },
    {
      "to": [
        "visualisation.oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model_species_labels"
      ],
      "from": "oncology_sbml_chareyron2009_mixed_immunotherapy_and_chemothera_model2001160002_model.species_labels"
    }
  ],
  "runtime": {
    "duration": 10,
    "initial_inputs": {},
    "communication_step": 1
  },
  "description": "Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes.Chareyron S1, Alamir M.Author informationAbstractIn this paper, a recently developed model governing the canc. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
  "schema_version": "2.0"
}